Meghan E. Brundage, Ph.D. - Publications
Affiliations: | Cancer and Cell Biology | University of Cincinnati, Cincinnati, OH |
Area:
Schwann cell developmentYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Brundage ME, Tandon P, Eaves DW, Williams JP, Miller SJ, Hennigan RH, Jegga A, Cripe TP, Ratner N. MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. Oncogene. 33: 5626-36. PMID 24509877 DOI: 10.1038/Onc.2013.506 | 0.426 | |||
2013 | Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, et al. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. The Journal of Clinical Investigation. 123: 340-7. PMID 23221341 DOI: 10.1172/Jci60578 | 0.426 | |||
Show low-probability matches. |